MRK — Merck & Co.

Health Care · NYSE/Nasdaq. Last price 133.72 USD (+0.69% on the day). Raven's AI 12-month target: 138.00 USD. Updated 2026-11-20.

Paper-trade Merck & Co. free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 138.00 USD (+3.91% from 132.81 when it was set on 2026-11-20). Conviction: medium.

Catalysts: Upcoming clinical trial readouts; Merger/acquisition announcements; Dividend hike or buyback

Risks: Patent cliff acceleration; FDA regulatory setback; Healthcare reform policy headwinds

Earnings

Q3 2026 earnings per share: 2.49 USD against 2.08 expected (beat by 19.6%). EPS estimates for 2026: 2.79 USD (26 analysts), 2027: 8.96 USD (25 analysts). The 2026 estimate has moved +1.5% over 90 days.

Dividends

Merck & Co. has paid 3.40 USD per share in dividends over the last 12 months (2.5% yield). Last dividend: 0.85 USD per share, ex-dividend 2026-09-15.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · ABT Abbott Laboratories · AMGN Amgen · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical

RAVEN is taking longer than usual to load.
RELOAD